Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis.

Front Pharmacol · 2025 · PMC12263634 · PMID 40672365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

There was no significant difference in the risk of AF/AFL between the high-dose SGLT2 inhibitors group and the low-dose SGLT2 inhibitors group (RR 0.78; 95%CI, 0.60–1.02; I 2 = 0%; P = 0.07), although a decreasing trend in the high-dose group was noted.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.